Karen Ling

BLCO

Karen Ling serves as Director at Bausch + Lomb Corporation (BLCO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$96.1K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$96.1K

Companies Traded

BLCO, TXMD

Active Period

Aug 2021 – Feb 2026

2 total trades

Most Recent

Buy BLCO

Feb 19, 2026 · $71.0K

Karen Ling's Insider Trading at Bausch + Lomb Corporation (BLCO)

Buys

1 · $71.0K

Sells

0 · $0.00

Total Shares Bought

4,000

Total Shares Sold

BLCO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026	Buy	4,000	$17.74	$71.0K	0

Karen Ling's Insider Trading at TherapeuticsMD, Inc. (TXMD)

Buys

1 · $25.1K

Sells

0 · $0.00

Total Shares Bought

33,445

Total Shares Sold

TXMD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2021	Buy	33,445	$0.75	$25.1K	130,309

Related Insiders

SAUNDERS BRENT L

CEO and Chairman of the Board

BLCOSell · Aug 5, 2025

Luc Bonnefoy

President, Surgical

BLCOSell · Jul 25, 2025

Sam Eldessouky

EVP and CFO

BLCOSell · Jul 25, 2025

Yehia Hashad

EVP of R&D and CMO

BLCOSell · Jul 25, 2025

Frederick Munsch

SVP, Controller and CAO

BLCOSell · Jul 25, 2025

VON ESCHENBACH ANDREW C.

Director

BLCOBuy · May 2, 2025

Explore More Insider Trading Data

BLCO Insider Trading Activity

View all insider trades at Bausch + Lomb Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity